Compare MUSA & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MUSA | GKOS |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 9.7B |
| IPO Year | 2013 | 2015 |
| Metric | MUSA | GKOS |
|---|---|---|
| Price | $535.93 | $244.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $616.00 | $242.46 |
| AVG Volume (30 Days) | 265.8K | ★ 1.5M |
| Earning Date | 10-28-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 28.09 | N/A |
| Revenue | ★ $21,529,400,000.00 | $507,442,000.00 |
| Revenue This Year | $45.07 | $53.82 |
| Revenue Next Year | N/A | $28.60 |
| P/E Ratio | $19.30 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $354.90 | $87.32 |
| 52 Week High | $636.05 | $255.19 |
| Indicator | MUSA | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 54.51 | 66.85 |
| Support Level | $489.90 | $143.30 |
| Resistance Level | $543.59 | $255.19 |
| Average True Range (ATR) | 18.45 | 14.15 |
| MACD | 2.03 | 1.46 |
| Stochastic Oscillator | 74.87 | 85.89 |
Murphy USA Inc is mainly engaged in the marketing of retail motor fuel products and convenience merchandise through a network of several retail stores in the Southwest, Southeast, Midwest, and Northeast United States. The majority of Murphy USA's stores are located in proximity to Walmart Supercenters, but it also operates standalone stores that market gasoline and other products under the Murphy USA, Murphy Express, and QuickChek brands. In addition, the company also markets fuel to unbranded wholesale customers through a mixture of company-owned and third-party product distribution terminals and pipeline positions. The firm generates maximum revenue through retail sales of petroleum products, and the rest from merchandise sales and wholesale of petroleum products.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.